US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

689.58

+12.761.88%

Number of Gainers:83

Number of Losers:58

Number of Flat:12

PE:- -

High:693.10

Open:676.83

Low:676.83

Close:676.82

Volume:344.85M

Turnover:10.20B

Market Cap:478.86B

Float Cap:363.49B

Loading ...

Ryan Specialty Names Dave Przesiek CEO of Ryan Specialty Benefits Unit

Candel Therapeutics Director Martine Zimmermann Files Initial Beneficial Ownership Statement

Coinbase Director Marc L Andreessen Disposes of 13,676 Shares Worth $2.48 Million

TransCode Therapeutics CFO Tom Fitzgerald Retires; John Tattory Named Interim CFO

Flywire General Counsel Peter Butterfield Disposes of Shares Worth $218,639.11

Transcode Therapeutics - Appoints John Tattory as Interim Chief Financial Officer Effective Immediately

THOMSON REUTERS

Transcode Therapeutics Announces Leadership Transition

THOMSON REUTERS

Press Release: TransCode Therapeutics Announces Leadership Transition

Lyell Immunopharma Expects 2027 FDA End-of-Phase 1 Meeting for Lyl273 Colorectal Cancer Trial

Robinhood Platform Assets Rise to $384 Billion at End-August 2026

Intapp CEO John T. Hall Disposes of $118,769 in Common Shares

Robinhood Markets, Inc. Reports August 2026 Operating Data

THOMSON REUTERS

Robinhood Markets, - Funded Customers at End of August 2026 were 28.6 Mln, up 1.90 Mln Year-over-Year

THOMSON REUTERS

Lyell Immunopharma, - Additional Clinical Data and End-of-Phase 1 FDA Meeting Expected in 2027

THOMSON REUTERS

Lyell Immunopharma Completes Manufacturing Transfer for Lyl273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer

THOMSON REUTERS

Press Release: Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Sophia Genetics Director Kathy L. Hibbs Sells 6,250 Shares for $50,817.50

Acumen Pharmaceuticals Announces Virtual Investor Day Meeting

Coinbase Wallet returns as Base App shifts to trading

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK4539/news?page=21"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":689.5794,"timestamp":1789675199999,"preClose":676.82104,"halted":0,"volume":344849106,"delay":0,"changeRate":0.01885,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":12.758362,"latestTime":"09-17 16:00:00 EDT","open":676.8309,"high":693.0984,"low":676.8309,"amount":10201629578.236523,"amplitude":0.024035,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.238276,"peRate":114.534565,"turnoverRate":0.026986,"increases":83,"decrements":59,"flats":8,"marketCap":478863276866.25,"floatMarketCap":363491613721},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":693.0984,"amplitude":0.024035,"preClose":676.82104,"low":676.8309,"pbRate":"5.238276","latestPrice":689.5794,"volume":344849106,"delay":0,"open":676.8309,"prevYearClose":881.5255,"prevWeekClose":693.0266,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":688.915,"twentyDayClose":674.9531,"sixtyDayClose":716.4692,"secType":"PLATE","market":"US","turnoverRate":0.026986,"peRate":114.534565,"marketCap":478863276866.25,"floatMarketCap":363491613721,"timestamp":1789675199999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":83,"down":58,"flat":12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:21,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666515154","title":"Ryan Specialty Names Dave Przesiek CEO of Ryan Specialty Benefits Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515154","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515154?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:22","pubTimestamp":1789071757,"startTime":"0","endTime":"0","summary":"Ryan Specialty names Dave Przesiek CEO of Ryan Specialty Benefits unitRyan Specialty named Dave Przesiek president and CEO of Ryan Specialty Benefits, effective immediately.Przesiek joined the benefit","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL1p2N6w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4173","RYAN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515151","title":"Candel Therapeutics Director Martine Zimmermann Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515151","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515151?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:22","pubTimestamp":1789071742,"startTime":"0","endTime":"0","summary":"Candel Therapeutics director Martine Zimmermann files initial beneficial ownership statementMartine Zimmermann filed an initial Form 3 as a director of Candel Therapeutics on Sept. 8, 2026.Disclaimer:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL259g1Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666051561","title":"Coinbase Director Marc L Andreessen Disposes of 13,676 Shares Worth $2.48 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666051561","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666051561?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:18","pubTimestamp":1789071522,"startTime":"0","endTime":"0","summary":"Coinbase director Marc L Andreessen disposes of 13,676 shares worth $2.48 millionCoinbase disclosed Director Marc L. Andreessen sold 13,676 Class A common shares on Sep. 8, 2026.The shares sold at a w","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL87BmYD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Coinbase Director Marc L Andreessen Disposes of 13,676 Shares Worth $2.48 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCK","BK4595","FDIG","FINX","CONY","COIX","LU1861558580.USD","BITQ","COIO","CONX","07711","BKCH","07311","BK4600","COII","BK4539","COIG","DAPP","COYY","BK4516","09311","BK4588","COIA","BK4112","CRPT","COIW","COIN","CONL","BK4596","CONI","IBLC","LU2360107671.USD","BK4554","BK4535","ICOI","09711","FIAT","LU1861217088.USD","LU1861220207.SGD","BK4585","BK4551","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515837","title":"TransCode Therapeutics CFO Tom Fitzgerald Retires; John Tattory Named Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515837","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515837?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:11","pubTimestamp":1789071074,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics CFO Tom Fitzgerald retires; John Tattory named interim CFOTransCode Therapeutics CFO Tom Fitzgerald retired. He resigned as CFO and as a director, effective immediately.John Tat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL6Z06gW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4539","BK4139","WINT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513093","title":"Flywire General Counsel Peter Butterfield Disposes of Shares Worth $218,639.11","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513093","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513093?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071028,"startTime":"0","endTime":"0","summary":"Flywire General Counsel Peter Butterfield disposes of shares worth $218,639.11Flywire General Counsel and CCO Peter Butterfield sold 12,156 shares of voting common stock on Sept. 8, 2026.Sale priced a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbG2GVT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Flywire General Counsel Peter Butterfield Disposes of Shares Worth $218,639.11","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLYW","BK4227","LU0757428866.USD","BK4106","BK4535","LU1815336091.USD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513083","title":"Transcode Therapeutics - Appoints John Tattory as Interim Chief Financial Officer Effective Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513083","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513083?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA5KVHNF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513055","title":"Transcode Therapeutics Announces Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513055","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513055?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA5KVHNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666156815","title":"Press Release: TransCode Therapeutics Announces Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2666156815","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666156815?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071000,"startTime":"0","endTime":"0","summary":"Tom Fitzgerald, Chief Financial Officer, Announces his RetirementJohn Tattory, to become Interim Chief Financial OfficerBOSTON, Sept. 10, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNA","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513741","title":"Lyell Immunopharma Expects 2027 FDA End-of-Phase 1 Meeting for Lyl273 Colorectal Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513741","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513741?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:09","pubTimestamp":1789070965,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma expects 2027 FDA End-of-Phase 1 meeting for LYL273 colorectal cancer trialLyell Immunopharma completed a manufacturing transfer for LYL273, its GCC-targeted CAR T-cell candidate for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL5qVy37:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210150020.SGD","IE00BGHQF748.EUR","NDAQ","BK4585","LU2095319765.USD","BK4588","IE00BN0W2T93.GBP","BCDF","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","LYEL","BK4112","BK4139","IE00BQXX3F31.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014021.USD","IE00BN0W2W23.USD","BK4539","LU2210149790.SGD","BK4505","IE00B64PRP62.GBP","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666051373","title":"Robinhood Platform Assets Rise to $384 Billion at End-August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666051373","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666051373?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:07","pubTimestamp":1789070872,"startTime":"0","endTime":"0","summary":"Robinhood platform assets rise to $384 billion at end-August 2026Robinhood reported August 2026 total platform assets of USD 384 billion, up 8% from July, up 26% year over year.Funded customers ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL3ykjNb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","BK4127","ROBN","FINX","BPAY","BK4547","HOOY","BLCK","BK4539","IAI","HOOX","HOOZ","HOOC","HOII","HOOW","HOYY","HOOI","LU1861559042.SGD","HOOD","CRPT","HOOG","HODU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666137515","title":"Intapp CEO John T. Hall Disposes of $118,769 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666137515","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666137515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:07","pubTimestamp":1789070865,"startTime":"0","endTime":"0","summary":"Intapp CEO John T. Hall disposes of $118,769 in common sharesIntapp CEO John T. Hall sold 3,000 common shares on Sep. 8 at a weighted-average USD 39.59.He exercised employee stock options for 3,000 sh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL8zsNKL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Intapp CEO John T. Hall Disposes of $118,769 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0757428866.USD","INTA","BK4535","LU1815336091.USD","BK4539","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513451","title":"Robinhood Markets, Inc. Reports August 2026 Operating Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513451?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA9CHMWF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HOOZ","HOOC","HOOG","ROBN","HOOI","BK4539","HOOY","CRPT","LU1861559042.SGD","BK4127","HOOD","FINX","BPAY","HOOW","BLCK","HODU","IAI","HOYY","BK4547","LU1861558580.USD","HOOX","HOII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666134085","title":"Robinhood Markets, - Funded Customers at End of August 2026 were 28.6 Mln, up 1.90 Mln Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2666134085","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666134085?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA9CHMWF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861558580.USD","BK4127","ROBN","FINX","BPAY","BK4547","HOOY","BLCK","BK4539","IAI","HOOX","HOOZ","HOOC","HOII","HOOW","HOYY","HOOI","LU1861559042.SGD","HOOD","CRPT","HOOG","HODU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666470513","title":"Lyell Immunopharma, - Additional Clinical Data and End-of-Phase 1 FDA Meeting Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666470513","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666470513?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA6NT6LB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","BK4539","LYEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666134805","title":"Lyell Immunopharma Completes Manufacturing Transfer for Lyl273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666134805","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666134805?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070701,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA6NT6LB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","LYEL","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513213","title":"Press Release: Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513213","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513213?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070700,"startTime":"0","endTime":"0","summary":"Former Incyte Executive Brings Extensive Oncology, Corporate Strategy, Business Development and Medical Affairs ExperienceMORRISTOWN, N.J., Sept. 10, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4231","BK4139","WHWK","BK4539","LENZ","ADC","NETL","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666240515","title":"Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666240515","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666240515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070700,"startTime":"0","endTime":"0","summary":"HUNTSVILLE, AL, Sept.  10, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Pl","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359971/0/en/serina-therapeutics-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4007","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666131775","title":"Sophia Genetics Director Kathy L. Hibbs Sells 6,250 Shares for $50,817.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2666131775","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666131775?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:02","pubTimestamp":1789070573,"startTime":"0","endTime":"0","summary":"Sophia Genetics director Kathy L. Hibbs sells 6,250 shares for $50,817.50Director Kathy L. Hibbs sold 6,250 ordinary shares on Sept. 8, 2026 at USD 8.13.Post-transaction holdings stood at 96,992 ordin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbgnWS7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Sophia Genetics Director Kathy L. Hibbs Sells 6,250 Shares for $50,817.50","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOPH","BK4539","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513911","title":"Acumen Pharmaceuticals Announces Virtual Investor Day Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513911","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513911?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:00","pubTimestamp":1789070432,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals announces virtual investor day meetingAcumen Pharmaceuticals will hold a virtual Investor Day meeting on September 16, 2026, in a virtual setting.Management is set to present up","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLcb2d8Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","SG9999014039.USD","SG9999014005.SGD","IE00BQXX3F31.USD","NDAQ","SG9999014013.SGD","LU0314104364.USD","SG9999014021.USD","ABOS","BK4112","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BK4585","BK4539","BK4139","BCDF","IE00BQXX3D17.EUR","IE00BGHQF748.EUR","BK4588","IE00B64PRP62.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513411","title":"Coinbase Wallet returns as Base App shifts to trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513411","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513411?lang=en_us&edition=fundamental","pubTime":"2026-09-11 03:56","pubTimestamp":1789070207,"startTime":"0","endTime":"0","summary":"Coinbase has restored the Coinbase Wallet name just over a year after replacing it with Base App, positioning the self-custodial product around multichain trading, perpetual futures, prediction markets and tokenized stocks.Coinbase Wallet will serve as a testing ground for assets unavailable on the company’s centralized exchange.The wallet supports 10 networks, including the newly added Robinhood Chain and Monad.Coinbase confirmed through its official Google Play listing that the Base App has returned to the Coinbase Wallet name as the product focuses on multichain trading, transfers, and earning features.Ryan Kass, head of Coinbase Wallet product, said in a statement that the wallet would function as a “test kitchen” for products and assets that Coinbase may not list on its centralized exchange. Long-tail tokens will appear once they are minted on supported networks, while the company plans to connect additional chains after they launch.“The Coinbase Wallet name better captures the pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/coinbase-wallet-returns-as-base-app-shifts-to-trading/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/coinbase-wallet-returns-as-base-app-shifts-to-trading/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["LU1861217088.USD","09711","IBLC","LU1861220207.SGD","BK4516","BK4596","BK4535","BK4600","CONI","07311","COIX","09311","FDIG","BITQ","CONX","BK4554","BK4595","LU2360107671.USD","BK4539","COII","CONL","COIG","ICOI","LU1861559042.SGD","BK4112","BK4551","CRPT","07711","COIW","BK4588","BKCH","CONY","COIA","FIAT","LU1861558580.USD","BK4585","COIN","BLCK","FINX","COIO","COYY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":40,"pageCount":21,"totalSize":800,"code":"91000000","status":"200"}]}}